Olumide Gbolahan

6PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 15, 2026
Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma.

|Jun 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.

|May 12, 2025
First-in-Human Study to Evaluate the Safety and Efficacy of Anti-GDF15 Antibody AZD8853 in Patients with Advanced/Metastatic Solid Tumors.

Benedito A Carneiro, Olumide B Gbolahan, Albiruni Abdul Abdul Razak

|Aug 18, 2022
Time to treatment initiation and its impact on real-world survival in metastatic colorectal cancer and pancreatic cancer.

Olumide Gbolahan, Neda Hashemi-Sadraei, Suri Yash

|Apr 11, 2022
Racial disparities in frailty and geriatric assessment impairments in older adults with cancer in the Deep South: Results from the CARE Registry.

Grant R Williams, Mustafa Al-Obaidi, Christian Harmon

|May 19, 2019
Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.

Olumide B Gbolahan, Yan Tong, Amikar Sehdev

Pageof 1

Frequent Collaborators

1 joint publications

Benedito A Carneiro

1 joint publications

Albiruni Abdul Abdul Razak

1 joint publications

John F Hilton

1 joint publications

Arthur W Lambert